Draft Guidance from the FDA Suggests Important Changes to Drug Development
source: shutterstock.com

Draft Guidance from the FDA Suggests Important Changes to Drug Development

On February 1, 2023, FDA issued a Draft Guidance Document, called “Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products” (Docket ID: FDA-2022-D-2983).  The Draft Guidance considers…

Continue Reading Draft Guidance from the FDA Suggests Important Changes to Drug Development
Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research
source: shutterstock.com

Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research

On April 12, 2023, Research!America, a Patient Worthy partner organization, hosted a webinar program titled Better Data for More Equitable Public Health Research. This talk featured Dr. Mary Pittman, President…

Continue Reading Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research
Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition
https://pixabay.com/en/board-school-task-auto-task-928392/

Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition

When Alexander Barron (9) was first born, doctors told his parents that he would likely never walk. In fact, said doctors, Alexander would probably not be very independent at all…

Continue Reading Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition
NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis
https://pixabay.com/en/dna-dns-biology-genetic-material-1388696/

NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis

The first few years of Saylor Baysden’s life involved a good deal of medical confusion. Her family pursued testing, leading to two diagnoses in 2020-21: autism and epilepsy. But her…

Continue Reading NC Family Raises SYNGAP1 Awareness After Daughter’s Diagnosis
New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
source: shutterstock.com

New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval

According to a press release from the US Food and Drug Administration (FDA), on March 24, 2023, the agency issued a new draft guidance titled Clinical Trial Considerations to Support Accelerated…

Continue Reading New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
Family Raises Funds for PDCD Research After Daughter’s Diagnosis
Source: https://pixabay.com/en/sky-clouds-rays-sun-hope-sunbeam-1107952/

Family Raises Funds for PDCD Research After Daughter’s Diagnosis

The Higbee family never planned to become rare disease advocates. But when their daughter Harlow began experiencing health issues, they knew that they would do whatever they could to help.…

Continue Reading Family Raises Funds for PDCD Research After Daughter’s Diagnosis

Mutual Trust Between Doctors and Parents of Children with Rare Diseases Means Optimum Care for the Child

The complexity of rare diseases makes communication between adults involved with the care of these children a vital tool. Communication and mutual trust are of the utmost importance. About the…

Continue Reading Mutual Trust Between Doctors and Parents of Children with Rare Diseases Means Optimum Care for the Child
LIVMARLI Now Approved for Children with Alagille Syndrome as Young as 3 Months Old
source: pixabay.com

LIVMARLI Now Approved for Children with Alagille Syndrome as Young as 3 Months Old

In many rare conditions, early diagnosis and treatment typically correspond with better outcomes. Prior to March 2023, LIVMARLI (maralixibat) was approved for the treatment of cholestatic pruritus related to Alagille…

Continue Reading LIVMARLI Now Approved for Children with Alagille Syndrome as Young as 3 Months Old